Quantcast

Latest Huntington's disease Stories

2014-06-24 10:39:41

Washington University in St. Louis Researchers believe they have learned how mutations in the gene that causes Huntington’s disease kill brain cells, a finding that could open new opportunities for treating the fatal disorder. Scientists first linked the gene to the inherited disease more than 20 years ago. Huntington’s disease affects five to seven people out of every 100,000. Symptoms, which typically begin in middle age, include involuntary jerking movements, disrupted...

2014-06-12 12:26:31

Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON, Mass., June 12, 2014 /PRNewswire/ -- Decision Resources Group finds that three therapies, Teva's Huntexil, Auspex's SD-809 and Raptor's Procysbi, will likely receive regulatory approval for Huntington's disease (HD) in the United States and the EU5 markets (Germany, France, Italy, Spain and United...

2014-05-26 13:27:58

Canadian Association for Neuroscience Mechanism uncovered could also help preserve neuron function in Alzheimer's disease, traumatic brain injury and other neurodegenerative conditions Research presented by Dr. Lynn Raymond, from the University of British Columbia, shows that blocking a specific class of glutamate receptors, called extrasynaptic NMDA receptors, can improve motor learning and coordination, and prevent cell death in animal models of Huntington disease. As Huntington...

2014-05-20 08:33:48

WASHINGTON, May 20, 2014 /PRNewswire/ -- Young people from Baltimore to Richmond impacted by Huntington Disease -- a hereditary, progressively degenerative brain disorder that leads to death and has no cure -- now have easy access to a broad range of support services, thanks to a pioneering international partnership spearheaded by the Huntington Disease Care, Education and Research Center at MedStar Georgetown University Hospital. Photo -...

2014-05-14 08:31:21

RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics(®) will be presented at the 17th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT). Fourteen oral and poster presentations, given by Sangamo scientists and their academic collaborators, will detail data from Sangamo's therapeutic and research programs...

2014-05-12 16:29:07

-- Secures Additional $50.4 Million in Cash in 1Q 2014 -- SEATTLE, May 12, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics targeting inflammation, coagulopathies and disorders of the central nervous system, today announced recent highlights and financial results for the first quarter of 2014, which include: -- 1Q 2014 net loss of $16.6...

2014-05-06 08:35:15

-Conference Call Webcast Tuesday, May 6, 11:30 a.m. ET at www.isispharm.com CARLSBAD, Calif., May 6, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013. Isis' first quarter 2014 pro forma NOL was higher than the same period last year primarily due to variations in the timing of milestone...

Scientists Hunt Down Origin Of Huntington's Disease In The Brain
2014-04-29 17:24:09

Elaine Schmidt, University of California - Los Angeles Health Sciences The gene mutation that causes Huntington's disease appears in every cell in the body, yet kills only two types of brain cells. Why? UCLA scientists used a unique approach to switch the gene off in individual brain regions and zero in on those that play a role in causing the disease in mice. Published in the April 28 online edition of Nature Medicine, the research sheds light on where Huntington's starts in the...

2014-04-24 10:52:56

TAU discovers that protein clusters implicated in neurodegenerative diseases actually serve to protect brain cells People diagnosed with Huntington's disease, most in their mid-thirties and forties, face a devastating prognosis: complete mental, physical, and behavioral decline within two decades. "Mutant" protein clusters, long blamed for the progression of the genetic disease, have been the primary focus of therapies in development by pharmaceutical companies. But according to new...

2014-04-23 08:32:23

WASHINGTON, April 23, 2014 /PRNewswire/ -- The only comprehensive, multidisciplinary center in Washington, D.C., that focuses on care, education and research for Huntington's Disease, a hereditary, progressively degenerative brain disorder that has no cure, has added a clinic in Maryland and is opening another in Virginia. Photo - http://photos.prnewswire.com/prnh/20140422/77314 Logo - http://photos.prnewswire.com/prnh/20140422/77315 A joint effort that Georgetown University...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related